BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Treatment
167 results:

  • 1. Combination tumor-treating fields treatment for patients with metastatic non-small cell lung cancer: A cost-effectiveness analysis.
    Liu K; Zhu Y; Zhu H; Zeng M
    Cancer Med; 2024 Mar; 13(5):e7070. PubMed ID: 38468503
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell lung cancer.
    Tsukita Y; Tozuka T; Kushiro K; Hosokawa S; Sumi T; Uematsu M; Honjo O; Yamaguchi O; Asao T; Sugisaka J; Saito G; Shiihara J; Morita R; Katakura S; Yasuda T; Hisakane K; Miyauchi E; Morita S; Kobayashi K; Asahina H
    JAMA Oncol; 2024 Apr; 10(4):439-447. PubMed ID: 38451530
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Developing a multi-institutional nomogram for assessing lung cancer risk in patients with 5-30 mm pulmonary nodules: a retrospective analysis.
    Jiang Y; Deng T; Huang Y; Ren B; He L; Pang M; Jiang L
    PeerJ; 2023; 11():e16539. PubMed ID: 38107565
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments.
    Peng H; Huang Z; Li P; Sun Z; Hou X; Li Z; Sang R; Guo Z; Wu S; Cao Y
    J Ethnopharmacol; 2024 Mar; 321():117518. PubMed ID: 38042385
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Survival after radiofrequency ablation and/or chemotherapy for lung cancer and pulmonary metastases: a systematic review and meta-analysis.
    Yang Z; Lyu X; Yang H; Wang B; Xu D; Huo L; Zhang R; Huang Y; Diao B
    Front Immunol; 2023; 14():1240149. PubMed ID: 37869011
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy.
    Mukhopadhyay S; Huang HY; Lin Z; Ranieri M; Li S; Sahu S; Liu Y; Ban Y; Guidry K; Hu H; Lopez A; Sherman F; Tan YJ; Lee YT; Armstrong AP; Dolgalev I; Sahu P; Zhang T; Lu W; Gray NS; Christensen JG; Tang TT; Velcheti V; Khodadadi-Jamayran A; Wong KK; Neel BG
    Cancer Res; 2023 Dec; 83(24):4095-4111. PubMed ID: 37729426
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Effect of Different Antitumor Regimens on Incidence and Severity of Corona Virus 
Disease 2019 Pneumonia in lung cancer Patients: 
A Single-center Retrospective Study].
    Lu W; Lv J; Wang Q; Yao Y; Wang D; Chen J; Wu G; Gu X; Li H; Chen Y; Han H; Lv T; Song Y; Zhan P
    Zhongguo Fei Ai Za Zhi; 2023 Jun; 26(6):429-438. PubMed ID: 37488080
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.
    Nicholson BD; Oke J; Virdee PS; Harris DA; O'Doherty C; Park JE; Hamady Z; Sehgal V; Millar A; Medley L; Tonner S; Vargova M; Engonidou L; Riahi K; Luan Y; Hiom S; Kumar H; Nandani H; Kurtzman KN; Yu LM; Freestone C; Pearson S; Hobbs FR; Perera R; Middleton MR
    Lancet Oncol; 2023 Jul; 24(7):733-743. PubMed ID: 37352875
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer.
    Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Dong Y; Geng Z; Zheng J; Lu X
    Apoptosis; 2023 Oct; 28(9-10):1315-1331. PubMed ID: 37336836
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CLIC4 Regulates Endothelial Barrier Control by Mediating PAR1 Signaling via rhoa.
    Kleinjan ML; Mao Y; Naiche LA; Joshi JC; Gupta A; Jesse JJ; Shaye DD; Mehta D; Kitajewski J
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1441-1454. PubMed ID: 37317855
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Solasodine suppresses the metastasis of gastric cancer through claudin-2 via the AMPK/STAT3/NF-κB pathway.
    Su K; Yao X; Guo C; Qian C; Wang Y; Ma X; Wang X; Yang Y
    Chem Biol Interact; 2023 Jul; 379():110520. PubMed ID: 37121296
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy.
    Sykes RA; Neves KB; Alves-Lopes R; Caputo I; Fallon K; Jamieson NB; Kamdar A; Legrini A; Leslie H; McIntosh A; McConnachie A; Morrow A; McFarlane RW; Mangion K; McAbney J; Montezano AC; Touyz RM; Wood C; Berry C
    Eur Heart J Cardiovasc Pharmacother; 2023 Jun; 9(4):371-386. PubMed ID: 37019821
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines.
    Tawfeeq N; Lazarte JMS; Jin Y; Gregory MD; Lamango NS
    Oncotarget; 2023 Mar; 14():243-257. PubMed ID: 36961909
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Epidemiological and Therapeutic Analyses in lung cancer Patients Over 80 Years Old in the Hokushin Region: A Retrospective Hospital Administrative Database Study.
    Koizumi T; Nishino Y; Takiguchi T; Kanda S; Otsuki K; Tanaka Y; Tomita R; Araki T; Hayashi R; Yasumoto K; Uramoto H; Hirono Y; Makino T; Nakada M; Yano S
    Clin Lung Cancer; 2023 Mar; 24(2):145-152. PubMed ID: 36639281
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Brain metastatic outgrowth and osimertinib resistance are potentiated by rhoa in EGFR-mutant lung cancer.
    Adua SJ; Arnal-Estapé A; Zhao M; Qi B; Liu ZZ; Kravitz C; Hulme H; Strittmatter N; López-Giráldez F; Chande S; Albert AE; Melnick MA; Hu B; Politi K; Chiang V; Colclough N; Goodwin RJA; Cross D; Smith P; Nguyen DX
    Nat Commun; 2022 Dec; 13(1):7690. PubMed ID: 36509758
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Thrombin induces IL-8/CXCL8 expression by DCLK1-dependent rhoa and YAP activation in human lung epithelial cells.
    Yuliani FS; Chen JY; Cheng WH; Wen HC; Chen BC; Lin CH
    J Biomed Sci; 2022 Nov; 29(1):95. PubMed ID: 36369000
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A retrospective comparative study of microwave ablation and sublobectomy in the treatment of early subpleural nonsmall cell lung cancer.
    Liu J; Wang C; Yi W; Zheng H; Zheng A
    Int J Hyperthermia; 2022; 39(1):1379-1386. PubMed ID: 36288915
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Influence of cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans.
    Leuva H; Zhou M; Brau N; Brown ST; Mundi P; Rosenberg TM; Luhrs C; Bates SE; Park YA; Fojo T
    Semin Oncol; 2022 Oct; 49(5):363-370. PubMed ID: 36055952
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. ARHGEF40 promotes non-small cell lung cancer proliferation and invasion via the AKT-Wnt axis by binding to rhoa.
    Gu J; Zhang X; Jiang G; Li Q; Wang E; Yu J
    Mol Carcinog; 2022 Nov; 61(11):1016-1030. PubMed ID: 36000254
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. GPR78 Regulates Autophagy and Drug Resistance in Non-small Cell lung cancer.
    Liao X; Cai R; Li G; Chen F
    Altern Ther Health Med; 2023 Jan; 29(1):130-136. PubMed ID: 35986740
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.